Honar Cherif

Adding Bortezomib and Bendamustine to High-Dose Melphalan in Autologous Haematopoietic Stem Cell Transplantation for Relapsed Multiple Myeloma-A Single Centre Retrospective Study

Silfverberg, Thomas; Cherif, Honar; Smitt, Emma; Carlson, Kristina

Part of eJHaem, 2026

• DOI for Adding Bortezomib and Bendamustine to High-Dose Melphalan in Autologous Haematopoietic Stem Cell Transplantation for Relapsed Multiple Myeloma-A Single Centre Retrospective Study
• Download full text (pdf) of Adding Bortezomib and Bendamustine to High-Dose Melphalan in Autologous Haematopoietic Stem Cell Transplantation for Relapsed Multiple Myeloma-A Single Centre Retrospective Study

Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study

Silfverberg, Thomas; Zjukovskaja, Christina; Ljungman, Per; Nahimi, Adjmal et al.

Part of Journal of Neurology, Neurosurgery and Psychiatry, p. 125-133, 2024

• DOI for Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study
• Download full text (pdf) of Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study

Antibiotic-induced microbiome disturbances in hematological patients undergoing hematopoietic stem cell transplantation: a prospective observational study

Montelin, Hanna; Hugerth, Luisa; Debelius, Justine; Melhus, Åsa et al.

2024

CSF Concentrations of CXCL13 and sCD27 Before and After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis

Lundblad, Katarina; Zjukovskaja, Christina; Larsson, Anders; Cherif, Honar et al.

Part of Neurology, 2023

• DOI for CSF Concentrations of CXCL13 and sCD27 Before and After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis
• Download full text (pdf) of CSF Concentrations of CXCL13 and sCD27 Before and After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis

Economic burden of sickle cell disease in Sweden: a population-based national register study with 13 years follow up

Kjellander, Christian; Hernlund, Emma; Ivergård, Moa; Svedbom, Axel et al.

Part of Frontiers in Hematology, 2023

• DOI for Economic burden of sickle cell disease in Sweden: a population-based national register study with 13 years follow up
• Download full text (pdf) of Economic burden of sickle cell disease in Sweden: a population-based national register study with 13 years follow up

Adding Bortezomib and Bendamustine to High-Dose Melphalan in Autologous Haematopoietic Stem Cell Transplantation for Relapsed Multiple Myeloma-A Single Centre Retrospective Study

Silfverberg, Thomas; Cherif, Honar; Smitt, Emma; Carlson, Kristina

Part of eJHaem, 2026

• DOI for Adding Bortezomib and Bendamustine to High-Dose Melphalan in Autologous Haematopoietic Stem Cell Transplantation for Relapsed Multiple Myeloma-A Single Centre Retrospective Study
• Download full text (pdf) of Adding Bortezomib and Bendamustine to High-Dose Melphalan in Autologous Haematopoietic Stem Cell Transplantation for Relapsed Multiple Myeloma-A Single Centre Retrospective Study

Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study

Silfverberg, Thomas; Zjukovskaja, Christina; Ljungman, Per; Nahimi, Adjmal et al.

Part of Journal of Neurology, Neurosurgery and Psychiatry, p. 125-133, 2024

• DOI for Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study
• Download full text (pdf) of Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study

CSF Concentrations of CXCL13 and sCD27 Before and After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis

Lundblad, Katarina; Zjukovskaja, Christina; Larsson, Anders; Cherif, Honar et al.

Part of Neurology, 2023

• DOI for CSF Concentrations of CXCL13 and sCD27 Before and After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis
• Download full text (pdf) of CSF Concentrations of CXCL13 and sCD27 Before and After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis

Economic burden of sickle cell disease in Sweden: a population-based national register study with 13 years follow up

Kjellander, Christian; Hernlund, Emma; Ivergård, Moa; Svedbom, Axel et al.

Part of Frontiers in Hematology, 2023

• DOI for Economic burden of sickle cell disease in Sweden: a population-based national register study with 13 years follow up
• Download full text (pdf) of Economic burden of sickle cell disease in Sweden: a population-based national register study with 13 years follow up

Next-generation sequencing of baseline genetic mutations and outcomes of eltrombopag and azacitidine therapy in patients with myelodysplastic syndromes and thrombocytopenia: Data from the SUPPORT clinical trial

Marques Ramos, Pedro; Choi, Jeea; Campbell, Catarina D.; Wang, Ying A. et al.

Part of eJHaem, p. 876-881, 2023

• DOI for Next-generation sequencing of baseline genetic mutations and outcomes of eltrombopag and azacitidine therapy in patients with myelodysplastic syndromes and thrombocytopenia: Data from the SUPPORT clinical trial
• Download full text (pdf) of Next-generation sequencing of baseline genetic mutations and outcomes of eltrombopag and azacitidine therapy in patients with myelodysplastic syndromes and thrombocytopenia: Data from the SUPPORT clinical trial

Impact of COVID-19 on patients treated with autologous hematopoietic stem cell transplantation: A retrospective cohort study

Silfverberg, Thomas; Wahlin, Bjorn; Carlson, Kristina; Cherif, Honar

Part of Upsala Journal of Medical Sciences, 2022

• DOI for Impact of COVID-19 on patients treated with autologous hematopoietic stem cell transplantation: A retrospective cohort study
• Download full text (pdf) of Impact of COVID-19 on patients treated with autologous hematopoietic stem cell transplantation: A retrospective cohort study

Biomarkers of demyelination and axonal damage are decreased after autologous hematopoietic stem cell transplantation for multiple sclerosis

Zhukovsky, Christina; Larsson, Anders; Cherif, Honar; Kultima, Kim et al.

Part of Multiple Sclerosis and Related Disorders, 2022

• DOI for Biomarkers of demyelination and axonal damage are decreased after autologous hematopoietic stem cell transplantation for multiple sclerosis
• Download full text (pdf) of Biomarkers of demyelination and axonal damage are decreased after autologous hematopoietic stem cell transplantation for multiple sclerosis

Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing-remitting multiple sclerosis: an observational study

Zhukovsky, Christina; Sandgren, Sofia; Silfverberg, Thomas; Einarsdottir, Sigrun et al.

Part of Journal of Neurology, Neurosurgery and Psychiatry, p. 189-194, 2021

• DOI for Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing-remitting multiple sclerosis: an observational study
• Download full text (pdf) of Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing-remitting multiple sclerosis: an observational study

Cancer risk in patients with primary immune thrombocytopenia - A Swedish nationwide register study

Ekstrand, Charlotta; Bahmanyar, Shahram; Cherif, Honar; Kieler, Helle et al.

Part of Cancer Epidemiology, 2020

• DOI for Cancer risk in patients with primary immune thrombocytopenia - A Swedish nationwide register study
• Download full text (pdf) of Cancer risk in patients with primary immune thrombocytopenia - A Swedish nationwide register study

Patient characteristics when starting treatment and patterns of treatment in adults with chronic immune thrombocytopenia

Ekstrand, Charlotta; Linder, Marie; Cherif, Honar; Kieler, Helle et al.

Part of Blood Coagulation and Fibrinolysis, p. 350-356, 2019

• DOI for Patient characteristics when starting treatment and patterns of treatment in adults with chronic immune thrombocytopenia

Patient fick rätt diagnos efter 50 års behandling för immunologisk trombocytopeni – Hade ärftlig trombocytopeni: [Patient was wrongly diagnosed and repeatedly treated for immune thrombocytopenia for 50 years]

Cherif, Honar; Greinacher, Andreas; Lubenow, Norbert

Part of Läkartidningen, 2018

Conjugated Pneumococcal Vaccine Triggers a Better Immune Response than Polysaccharide Pneumococcal Vaccine in Patients with Chronic Lymphocytic Leukemia: A Randomized Study by the Swedish CLL group

Svensson, Tobias; Kättström, Magdalena; Hammarlund, Ylva; Roth, Daniel et al.

Part of Vaccine, p. 3701-3707, 2018

• DOI for Conjugated Pneumococcal Vaccine Triggers a Better Immune Response than Polysaccharide Pneumococcal Vaccine in Patients with Chronic Lymphocytic Leukemia: A Randomized Study by the Swedish CLL group

Azacitidine with or without eltrombopag for first-line treatment of intermediate- or high-risk MDS with thrombocytopenia

Dickinson, Michael; Cherif, Honar; Fenaux, Pierre; Mittelman, Moshe et al.

Part of Blood, p. 2629-2638, 2018

• DOI for Azacitidine with or without eltrombopag for first-line treatment of intermediate- or high-risk MDS with thrombocytopenia

Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler's Disease, Uppsala University Hospital

Karlsson, Torbjörn; Cherif, Honar

Part of Upsala Journal of Medical Sciences, p. 153-157, 2018

• DOI for Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler's Disease, Uppsala University Hospital
• Download full text (pdf) of Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler's Disease, Uppsala University Hospital

Eltrombopag In Combination With Azacitidine For First-Line Treatment Of Mds Patients With Thrombocytopenia: The Randomized, Placebo-Controlled, Phase Iii, Support Study

Dickinson, M.; Cherif, Honar; Fenaux, P.; Mittelman, M. et al.

Part of Leukemia Research, 2017

Utility of bronchoalveolar lavage in diagnosing respiratory tract infections in patients with hematological malignancies: are invasive diagnostics still needed?

Svensson, Tobias; Lundström, Kristina Lamberg; Höglund, Martin; Cherif, Honar

Part of Upsala Journal of Medical Sciences, p. 56-60, 2017

• DOI for Utility of bronchoalveolar lavage in diagnosing respiratory tract infections in patients with hematological malignancies: are invasive diagnostics still needed?
• Download full text (pdf) of Utility of bronchoalveolar lavage in diagnosing respiratory tract infections in patients with hematological malignancies: are invasive diagnostics still needed?

Pharmacological agents preceding a diagnosis of immune thrombocytopenia in adult patients developing the chronic form: A Swedish national register study

Löfling, Lukas; Linder, Marie; Ekstrand, Charlotta; Cherif, Honar et al.

Part of Thrombosis Research, p. 27-31, 2017

• DOI for Pharmacological agents preceding a diagnosis of immune thrombocytopenia in adult patients developing the chronic form: A Swedish national register study
• Download full text (pdf) of Pharmacological agents preceding a diagnosis of immune thrombocytopenia in adult patients developing the chronic form: A Swedish national register study

An open-label phase I dose-finding study of APR-246 in hematological malignancies

Deneberg, S.; Cherif, Honar; Lazarevic, V.; Andersson, P-O et al.

Part of Blood Cancer Journal, 2016

• DOI for An open-label phase I dose-finding study of APR-246 in hematological malignancies
• Download full text (pdf) of An open-label phase I dose-finding study of APR-246 in hematological malignancies

Infection and Anti-Infective Treatment Preceding a Diagnosis of Primary Persisting Immune Thrombocytopenia

Sohrabian, Donia; Linder, Marie; Ekstrand, Charlotta; Cherif, Honar et al.

Part of Pharmacoepidemiology and Drug Safety, p. 88-88, 2016

• DOI for Infection and Anti-Infective Treatment Preceding a Diagnosis of Primary Persisting Immune Thrombocytopenia

Characteristics of Patients at Initiation of Treatment for Primary Chronic Immune Thrombocytopenia

Ekstrand, Charlotta; Linder, Marie; Cherif, Honar; Kieler, Helle et al.

Part of Pharmacoepidemiology and Drug Safety, p. 197-197, 2016

• DOI for Characteristics of Patients at Initiation of Treatment for Primary Chronic Immune Thrombocytopenia

General Pharmacological Treatments Preceding A Primary Chronic Immune Thrombocytopenia Diagnosis

Lofling, Lukas; Linder, Marie; Ekstrand, Charlotta; Cherif, Honar et al.

Part of Pharmacoepidemiology and Drug Safety, p. 645-646, 2016

• DOI for General Pharmacological Treatments Preceding A Primary Chronic Immune Thrombocytopenia Diagnosis

Effect of intravenous iron supplementation on iron stores in non-anemic iron-deficient patients with hereditary hemorrhagic telangiectasia

Karlsson, Torbjörn; Cherif, Honar

Part of Hematology Reports, 2016

• DOI for Effect of intravenous iron supplementation on iron stores in non-anemic iron-deficient patients with hereditary hemorrhagic telangiectasia
• Download full text (pdf) of Effect of intravenous iron supplementation on iron stores in non-anemic iron-deficient patients with hereditary hemorrhagic telangiectasia

Increased susceptibility to infections before the diagnosis of immune thrombocytopenia

Ekstrand, C.; Linder, M.; Cherif, Honar; Kieler, H. et al.

Part of Journal of Thrombosis and Haemostasis, p. 807-814, 2016

• DOI for Increased susceptibility to infections before the diagnosis of immune thrombocytopenia

Susceptibility to Infection before Diagnosis of Primary Chronic Immune Thrombocytopenia

Ekstrand, Charlotta; Linder, Marie; Cherif, Honar; Kieler, Helle et al.

Part of Pharmacoepidemiology and Drug Safety, p. 519-519, 2015

Increased Anti-infective Treatments Preceding a Diagnosis of Primary Immune Thrombocytopenia

Ekstrand, Charlotta; Linder, Marie; Cherif, Honar; Kieler, Helle et al.

Part of Pharmacoepidemiology and Drug Safety, p. 411-412, 2015

Combination treatment with an erythropoiesis-stimulating agent and intravenous iron alleviates anaemia in patients with hereditary haemorrhagic telangiectasia

Cherif, Honar; Karlsson, Torbjörn

Part of Upsala Journal of Medical Sciences, p. 350-353, 2014

• DOI for Combination treatment with an erythropoiesis-stimulating agent and intravenous iron alleviates anaemia in patients with hereditary haemorrhagic telangiectasia

A pilot phase I dose finding safety study of the thrombopoietin-receptor agonist, eltrombopag, in patients with myelodysplastic syndrome treated with azacitidine

Svensson, Tobias; Chowdhury, Onima; Garelius, Hege; Lorenz, Fryderyk et al.

Part of European Journal of Haematology, p. 439-445, 2014

• DOI for A pilot phase I dose finding safety study of the thrombopoietin-receptor agonist, eltrombopag, in patients with myelodysplastic syndrome treated with azacitidine

Clinical experience of granulocyte transfusion in the management of neutropenic patients with haematological malignancies and severe infection

Cherif, Honar; Axdorph, Ulla; Kalin, Mats; Björkholm, Magnus

Part of Scandinavian Journal of Infectious Diseases, p. 112-116, 2013

• DOI for Clinical experience of granulocyte transfusion in the management of neutropenic patients with haematological malignancies and severe infection

Adjuvanted influenza a (H1N1) 2009 vaccine in patients with hematological diseases: good safety and immunogenicity even in chemotherapy-treated patients

Cherif, Honar; Höglund, Martin; Pauksens, Karlis

Part of European Journal of Haematology, p. 413-419, 2013

• DOI for Adjuvanted influenza a (H1N1) 2009 vaccine in patients with hematological diseases: good safety and immunogenicity even in chemotherapy-treated patients

Clinical significance of serum immunoglobulin G subclass deficiency in patients with chronic lymphocytic leukemia

Svensson, Tobias; Höglund, Martin; Cherif, Honar

Part of Scandinavian Journal of Infectious Diseases, p. 537-542, 2013

• DOI for Clinical significance of serum immunoglobulin G subclass deficiency in patients with chronic lymphocytic leukemia

Answer to "Letter to the Editor, Scandinavian Journal of Infectious Diseases"

Svensson, Tobias; Cherif, Honar; Höglund, Martin

Part of Scandinavian Journal of Infectious Diseases, p. 730-730, 2013

• DOI for Answer to "Letter to the Editor, Scandinavian Journal of Infectious Diseases"

Hematological: Low all-cause mortality and low occurrence of antimicrobial resistance in hematological patients with bacteremia receiving no antibacterial prophylaxis: a single-center study

Kjellander, Christian; Bjorkholm, Magnus; Cherif, Honar; Kalin, Mats et al.

Part of European Journal of Haematology, p. 422-430, 2012

• DOI for Hematological: Low all-cause mortality and low occurrence of antimicrobial resistance in hematological patients with bacteremia receiving no antibacterial prophylaxis: a single-center study

Targeting p53 in Vivo: a First-in-Human Study With p53-Targeting Compound APR-246 in Refractory Hematologic Malignancies and Prostate Cancer

Lehmann, Sören; Bykov, Vladimir J N; Ali, Dina; Andrén, Ove et al.

Part of Journal of Clinical Oncology, p. 3633-3639, 2012

• DOI for Targeting p53 in Vivo: a First-in-Human Study With p53-Targeting Compound APR-246 in Refractory Hematologic Malignancies and Prostate Cancer

Influenza A H1N1 2009 Vaccine in Patients with Hematological Diseases: Good Safety and Immunogenicity Even in Heavily Chemotherapy-Treated Patients

Cherif, Honar; Höglund, Martin; Pauksens, Karlis

Part of Blood, p. 1054, 2012

Antibiotic-induced microbiome disturbances in hematological patients undergoing hematopoietic stem cell transplantation: a prospective observational study

Montelin, Hanna; Hugerth, Luisa; Debelius, Justine; Melhus, Åsa et al.

2024